Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.400
+0.040 (2.94%)
At close: Aug 25, 2026, 4:00 PM EDT
1.409
+0.009 (0.61%)
Pre-market: Aug 26, 2026, 9:04 AM EDT
Ocugen Employees
Ocugen had 116 employees as of December 31, 2025. The number of employees increased by 21 or 22.11% compared to the previous year.
Employees
116
Change (1Y)
21
Growth (1Y)
22.11%
Revenue / Employee
$39,491
Profits / Employee
-$705,267
Market Cap
474.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 116 | 21 | 22.11% |
| Dec 31, 2024 | 95 | 30 | 46.15% |
| Dec 31, 2023 | 65 | -19 | -22.62% |
| Dec 31, 2022 | 84 | 28 | 50.00% |
| Dec 31, 2021 | 56 | 41 | 273.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| Puma Biotechnology | 179 |
| Editas Medicine | 87 |
| Prothena Corporation | 67 |
| Eupraxia Pharmaceuticals | 49 |
| Compass Therapeutics | 39 |
| Inhibikase Therapeutics | 35 |
| Q32 Bio | 22 |
OCGN News
- 1 day ago - Ocugen to Participate in Upcoming September Investor and Industry Conferences - GlobeNewsWire
- 12 days ago - Ocugen Proxy statement: Proxy filing - Filings
- 14 days ago - Ocugen Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 20 days ago - Ocugen Earnings Call Transcript: Q2 2026 - Transcripts
- 20 days ago - Ocugen Earnings release: Q2 2026 - Filings
- 20 days ago - Ocugen Quarterly report: Q2 2026 - Filings
- 20 days ago - Ocugen reports Q2 EPS (7c), consensus (5c) - TheFly
- 20 days ago - Ocugen Provides Business Update with Second Quarter 2026 Financial Results - GlobeNewsWire